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ABSTRACT 
Objective.  To  evaluate  the  prevalence  of  human  herpesviruses  1-6  and  community-acquired 
respiratory viruses (CARVs) in specimens from patients with nasal polyposis undergoing functional 
endoscopic sinus surgery (FESS) and investigate the potential clinical role. 
Methods. Viral occurrence was evaluated by molecular methods in polyps, turbinate mucosa, pre- 
and post-operative  scraping specimens  from 35 consecutive  patients  at  different  time  points  in 
relation to FESS. 
Results. Overall, 21 patients (60%) were positive to at least one virus in at least one specimen; in  
particular,  12.1%  of  all  specimens  for  HHV-6  (3/35  polyps,  11/31  turbinates,  1  pre-surgical 
scraping)  and  10.5% for  EBV (8/35  polyps,  3/31  turbinates,  1/29  pre-  and  1/29  post-surgical 
scraping), followed by CMV and HSV-1 (both 1.6%; 1/35 polyps, 1/29 post-surgical scraping and 
2/35 polyps,  respectively).  EBV-positivity  tended to be higher  in polyps,  as well  as HHV-6 in 
adiacent healthy turbinate mucosa, although no significant association was found. Only one pre-
operative cytological specimen was positive to parainfluenza virus-1. 
Conclusion.  No association between the development of nasal polyps, herpesviruses and CARVs 
seem to exist.  However, the higher EBV frequency in polyps could suggest a causative role or 
persistence in the inflammatory lymphoid tissue. 
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INTRODUCTION
Nasal polyps are a common chronic disease of nasal and paranasal sinus mucosa, which affects  
approximately 4% of general population. These benign lesions are characterized by inflammation-
induced mucosal swelling, inflammatory cell infiltration, and subepithelial edema. Nasal polyps are 
usually  associated  with  chronic  rhinosinusitis  (CRSwNP)  and  most  common  symptoms  are 
obstruction, rhinorrhea, anosmia, facial pain and headache [1]. Medical therapy consists of  intra-
nasal steroids [2] and antibiotics [3]; nevertheless functional endoscopic sinus surgery (FESS) is 
often necessary, despite of 70% chance of recurrence [4]. Pathogenesis and molecular mechanisms 
underlying CRSwNP are poorly known; several factors have been investigated, including Kirsten 
rat sarcoma (K-RAS) codon 12 mutations/increased expression [5], elevated expression of Vascular 
endothelial growth factor (VEGFA) and Transforming growth factor-B1 (TGFB1) [6,7], as well as 
clinical features, including allergy, asthma, immunodeficiency and chronic sinus infections [8,9]. 
Viral  infections  have  been  hypothesized  to  play  a  role  in  the  pathogenesis,  progression  and 
recurrence of CRSwNP [10]. While human papillomavirus has been associated rather to neoplastic 
lesions  [11-13], very  few  studies  have  investigated  the  role  of  herpesviruses  and  community-
acquired  respiratory  viruses  (CARVs)  with  no  definitive  conclusions  [14]. The  Herpesviridae 
family encompasses several DNA viruses, that are able to establish lifelong latent infections and 
reactivate in immunocompromised conditions; in particular,  human herpesviruses 1-6 (including 
HSV-1 and 2,  VZV, EBV, CMV) are  highly  seroprevalent  and have  been associated  to  upper 
airway infections. 
The  aim  of  this  study  was  to  evaluate  human  herpesviruses  1-6  and  CARVs  prevalence  by 
molecular  methods  in  nasal  polyps,  adjacent  inferior/middle  turbinates,  pre-  and post-operative 
nasal scraping from patients undergoing FESS. 
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MATERIALS AND METHODS
Study population consisted of 35 consecutive patients (M/F, 25/10; mean age±standard deviation, 
50.3±15.4 years;  range,  23-77)  with CRSwNP undergoing FESS between September  2011 and 
April 2012 (Table 1).  All the patients gave their informed consent and the study was approved by 
the institutional review board. Diagnosis of CRSwNP was made on the basis of European Position 
Paper on Rhinosinusitis and Nasal Polyps (EPOS) 2012 criteria [1]. In details, diagnostic criteria 
included  inflammation  of  the  nose  and  the  paranasal  sinuses  characterized  by  two  or  more 
symptoms,  one  of  which  being  either  nasal  blockage/obstruction/congestion  or  nasal  discharge 
(anterior/posterior  nasal  drip);  facial  pain/pressure;  reduction/loss  of  smell  for  ≥12  weeks; 
supported  by  endoscopic  signs  of  nasal  polyps,  mucopurulent  discharge,  oedema/mucosal 
obstruction and/or computed tomography changes. All patients were affected by CRS with  multiple 
polyps arising from the middle turbinate, middle meatus, or ethmoidal sinuses and were classified 
as grade II-III according to the Mackay and Lund system [15]. Pediatric subjects, HIV-seropositive 
individuals, patients with cystic fibrosis, immotile cilia syndrome, allergic fungal rhinosinusitis and 
inverted papilloma were excluded. The following time points were considered: T0  (one month pre-
surgery)  clinical  history  for  allergy  and  asthma (previous  investigation  by prick  test)  and pre-
operative cytological specimen; T1 (surgery) collection of two bioptic samples of polyps and the 
adjacent inferior/middle turbinates without polyposis; T2 (one month post-surgery) post-operative 
cytological specimen (Figure 1). Polyp specimens were collected from maxillary or ethmoid sinus, 
depending on the involved site; scraping for cytological samples was performed on inferior/middle 
turbinates. Due to missing sending or inadequacy, only 31, 29, and 29 turbinates, pre- and post-
operative scraping specimens were available, respectively, for an overall number of 124 samples for 
molecular testing.
For processing of mucosa tissues, specimens were incubated with 200 µl lysis buffer (Tissue Lysis 
Buffer, Qiagen, Milan, Italy) by brief vortexing and heating at 100°C for 5 min twice, vortexed 
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briefly  again,  then  centrifuged  for  1  min  at  13,000 rpm at  room temperature.  Subsequently,  a 
mechanical lysis step with  the rotor-stator homogenizer Tissue Ruptor  was performed.  A 200 µl 
aliquot of supernatant,  as well as of nasal scraping, was subjected to nucleic acid extraction using 
the Nuclisens EasyMAG platform (Biomerieux, Marcy l’Etoile, France). 
For  herpesviruses  1-6  detection  and  quantification,  real-time  PCR  was  performed,  using 
commercially available  kits  (Q-PCR Complete  Kit  [ELItech  group, Milan,  Italy])  following the 
manufacturer’s instructions, and the 7500 Real-Time PCR System (Applied Biosystems, Monza, 
Italy). Target regions were glycoprotein D and G for HSV-1 and HSV-2, respectively; ORF 29 for  
VZV;   EBNA 1 for EBV; exon 4 and UL 123 for CMV; and ORF 13R for HHV6. 
The occurrence of CARVs was investigated using a commercially available multiplex PCR assay 
according to the manufacturer’s instructions (RV15 OneStep ACE Detection  [Seeplex®; Seegene, 
Seoul, Korea]), targeting sequences of Influenza A and B viruses, RSV type A and B, adenovirus, 
metapneumovirus,  coronaviruses  229E/NL63 and OC43, parainfluenza  viruses  1-4,  rhinoviruses 
A/B/C, enteroviruses, and  bocaviruses 1/2/3/4 and the MultiNA System  (Shimadzu Corporation 
Italia, Milan, Italy). 
For statistical analysis, the chi square and Fisher’s exact tests were applied, as appropriate. A p-
value <0.05 was considered statistically significant.
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RESULTS
Results are summarized in Tables 2. Overall, 21 patients (60%) were positive to at least one virus in 
at least one specimen. As regards herpesviruses 1-6, the highest prevalence was found for HHV-6 
(15/124;  12.1%; mean  viral  load  1620±1837 copies/104 cells;  median,  820)  and EBV (13/124; 
10.5%; mean viral load 88±140; median, 25), followed by CMV and HSV-1 (both 2/124; 1.6%). No 
specimen was positive to HSV-2 and VZV. In Table 2, prevalence and viral load in different sites  
for each virus are reported. Viral load was ≤3x103 copies/104 cells in all the cases, except for HHV-
6 on a polyp specimen (see below). Considering the type of specimen, EBV was found in eight,  
three, and two polyp, turbinate and cytological (one T0 and one T2) specimens, respectively. In one 
patient, EBV was positive in both polyp and turbinate specimens; in another individual in polyp,  
turbinate and post-operative cytological samples. In both cases, the highest viral load was found in 
polyp specimens. HHV-6 was positive in three polyps, 11 turbinates, and one T0 scraping specimen. 
In two patients, both polyp and turbinate specimens were positive to HHV-6, with the highest viral 
load being detected in the polyp sample (49000 copies/104 cells). HSV-1 was found in two polyp 
samples, one also positive to EBV. CMV was found in one polyp (also EBV-positive) and in a T 2 
scraping (other samples from the same patient were negative to herpesviruses 1-6). Although EBV-
positivity tended to be higher in polyps in comparison to other specimens, as well as HHV-6 in 
turbinate mucosa in comparison to other samples, no statistically significant association was found. 
Similarly, no significant association between EBV and HHV-6 positivity on polyps and turbinate 
mucosa, respectively, and clinical features of allergy and asthma was found. As regards CARVs, 
only one pre-operative cytological specimen was positive to parainfluenza virus 1. 
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DISCUSSION
In this study, the prevalence of herpesviruses 1-6 and CARVs in polyp, turbinate mucosa and nasal 
cytological specimens from patients undergoing FESS for CRSwNP was investigated.
Considering herpesviruses, the highest prevalence was found for HHV-6 (12.1%, irrespective of the 
type of specimen), followed by EBV (10.5%). CMV and HSV-1 prevalence was very low, while no 
specimen resulted positive for other herpesviruses. These results are different from those reported in 
previous studies. As regards EBV, old studies reported EBV-DNA qualitative detection by PCR in 
80% of normal nasopharingeal mucosa from Chinese subjects [16,17]. In another study on 13 nasal 
polyps,  the  same  Authors  found EBV prevalence  of  15%,  69%,  and 85% using southern  blot 
hybridization, qualitative PCR, and in situ hybridization, respectively [18]; this study evidenced a 
highly different sensitivity with these different methods and lead the author to hypothesized that 
nasal mucosa is a site where EBV persists through a low replicative level in resident lymphocytes. 
More  recently,  a  35% EBV positivity  in  23  nasal  polyps  was  found by qualitative  PCR [19]; 
whereas in a study on nasal polyps  and hypertrophied turbinates  from Hong Kong patients,  no 
specimen was positive to EBV in situ hybridization [20]. Taking into account also the different 
methods and particularly the absence of quantitative molecular data in previous studies, it could be 
argued that EBV-positivity in polyps represents its presence in the inflammatory lymphoid tissue. 
This hypothesis  could be further supported by the fact that EBV was detected at  lower rate in 
healthy tissue (turbinate mucosa) than in polyps, although the difference was not significant, and by 
the fact that viral load was always within an order of magnitude of 102 copies/104 cells. Although 
EBV can persist in that lymphocytes can be infected by virus released from a lytic EBV infection in  
the nasal mucosa, the fact that EBV is detected in high rate in normal nasopharyngeal mucosa tissue 
(up to 88% in some studies [18]), whereas nasal polyps are much rarer, argues against an EBV 
contribution to polyp development. This is further supported by data on viral load of the present 
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study and the low number of EBV+ cells in each positive case described by Tao and colleagues 
[18].
Only one study investigated HHV-6 prevalence in polyps and inferior turbinates without finding 
any positive specimen [19]. This is in contrast to the present study in which HHV-6 was detected in 
>35% of turbinate mucosa specimens and >8% of nasal polyps. This difference could be due to the 
different methods: quantitative real-time PCR with high specificity and sensibility in the present 
study, traditional PCR with 70 bp amplicon length in the study by Zaravinos. The relatively high 
HHV-6-prevalence in healthy tissues found in our study could be due to its frequent occurrence and 
diffusion  in  different  tissues.  HHV-6  seroprevalence  is  the  highest  amongst  herpesviruses; 
furthermore HHV-6 is the only herpesvirus which is able to integrate its DNA in human genome, as 
it  can  be  detectable  in  chromosomically  integrated  status  in  0.2-0.8%  of  general  population. 
Persistence of HHV-6 involves both a true latent state and a low-level chronic replication, each 
occurring at different anatomic sites, including nasal mucosa. It is to note that a possible limitation 
of this study is the lack of healthy controls, as well as of normal sinonasal specimens from patients 
with other underlying pathologies.
Furthermore,  we evaluated the presence of CARVs using a multiplex-PCR and found only one 
cytological sample positive to parainfluenza virus-1. These results are in accordance with a previous 
study on 13 sinonasal mucosa specimens from chronic rhinosinusitis patients and two from healthy 
subjects, that resulted negative to a panel of 12 CARVs [21]. Other Authors evaluated the presence 
of  picornaviruses  in  nasal  washing and turbinate  mucosa  from 39 patients  affected  by chronic 
rhinosinusitis and 27 healthy people and found a 21% rhinovirus positivity in patients, while no 
virus  was found in controls  [22].  A more  recent  study investigated  CARVs in  paranasal  sinus 
mucosa and polyps by multiplex-PCR and found a 18% positivity to bocavirus and <2% positivity 
to rhinovirus in 102 tissue samples from 88 patients [23]. In the present study, the lack of CARVs 
detection  in  any  specimen  (but  the  cytological  sample)  seems  to  argue  against  a  potential 
involvement of these viruses in this clinical context.
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In  conclusion,  only  EBV and  HHV-6  were  detected  at  certain  frequency  in  nasal  polyps  and 
adjacent  turbinate  mucosa  specimens,  respectively,  although with no statistical  significance.  To 
date, the data obtained by the present and other studies seem to argue against a definite role for 
herpesviruses and CARVs in the development of nasal polyps. Future studies should taken in to 
account the relatively higher frequency of EBV detection in polyps, that could suggest a causative 
role in the formation of nasal polyps, as previously suggested by others, or EBV persistence in the 
inflammatory lymphoid tissue which characterizes these lesions. 
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Table 1. Demographic and clinical features of study population. 
Patients characteristics N 
(Total=35)
(%)
Gender (M/F) 20/15 -
Age (mean ± SD; range) 50.3 ±  15.4 -
Allergy 15 42.9
Asthma 8 22.9
Fanily anamnesis 
  Asthma/allergy
  Nasal polyposis
10
3
28.6
8.6
Previous sinusal surgery 10 28.6
Nasal obstruction (visual analog scale 0-10)
  0-4
  5-8
  9-10
5
15
15
14.4
42.8
42.8
Anterior discharge 20 57.1
Posterior discharge 13 37.1
Loss of smell (any grade) 32 91.4
Facial pain 11 31.4
1
2
1
Table 2. Herpesviruses 1-6 detection and viral load on polyp, turbinate mucosa, pre- and post-
operative  scraping  specimens  from patients  with  chronic  rhinosinusitis  with  nasal  polyps 
undergoing  functional endoscopic sinus surgery. For each virus the following data are reported: 
raw number and percentage; viral load as mean±standard deviation and median when more than two 
specimens are positive; otherwise, single results. Viral load is expressed as copies/104 cells.
Samples
(N= 124)
HSV-1 HSV-2 VZV CMV EBV HHV-6
Polyps  (N= 35) 2 (5.7%)
25; 19
0 0 1 (2.9%)
35
8 (22.9%)
157±197
70
3 (8.6%)
16580±28076
440
Turbinates (N= 31) 0 0 0 0 3 (9.7%)
23±3
25
11 (35.5%)
705±1264
37
Pre-surgical scraping (N=29) 0 0 0 0 1 (3.4%)
12
1 (3.4%)
4400
Post-surgical scraping (N=29) 0 0 0 1 (3.4%) 1 (3.4%)
20
0
2 (1.6%) 0 0 2 (1.6%) 13 (10.5%) 15 (12.1%)
3
4
5
6
7
8
9
10
11
12
13
2
Figure 1.  Synopsis  of  specimen collection in  study population.  FESS,  functional 
endoscopic sinus surgery.
